BENGALURU - India's government said on Tuesday it has approved Gilead Sciences's antiviral drug remdesivir for emergency use in treating Covid-19 patients.
Remdesivir is the first drug to show improvement in Covid-19 patients in formal clinical trials. It was granted emergency use authorisation by the US Food and Drug Administration last month and has received approval by Japanese health regulators. " approved on June 1 under emergency use with condition for five dose administration," the Drugs Controller General of India said in an e-mail statement.As of Tuesday, India has 198,706 cases of coronavirus and has recorded 5,598 deaths, health ministry data showed.
Gilead Sciences had on Monday reported that remdesivir showed modest benefit in patients with moderate Covid-19 given a five-day course, while those who received it for 10 days in the study did not fare as well. European and South Korean authorities are also looking at remdesivir, with South Korean health authorities last Friday saying they would request imports of the drug. Gilead is yet to gain regulatory approval in either market.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Russia to start using its first drug approved to treat Covid-19MOSCOW: Russia will roll out its first drug approved to treat Covid-19 patients next week, its state financial backer told Reuters, a move it hopes will ease strains on the health system and speed a return to normal economic life. Russian hospitals can begin giving the...
Source: thenewpaper - 🏆 7. / 63 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: The Straits Times - 🏆 8. / 63 Read more »
Source: TODAYonline - 🏆 1. / 99 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »